Verily

A photo of Verily's headquarters in South San Francisco.
By Dave Muoio 02:08 pm October 27, 2020
Yesterday, Kaiser Health News reported that California's San Francisco and Alameda counties had "severed ties" with a highly publicized "Project Baseline" COVID-19 testing program supported by Alphabet's Verily Life Sciences. In particular, the reporting focused on Verily-backed community testing sites located in Oakland that have been closed for months, one of which is now working to reopen with...
By Laura Lovett 03:17 pm August 25, 2020
Alphabet’s life science subsidiary Verily is jumping into the health insurance game with the launch of its new venture Coefficient Insurance Company.  The tech-enabled payer will be backed by Swiss Re Corporate Solutions, which specializes in data-driven risk assessments.  Coefficient, which is categorized as a Verily subsidiary, is targeted at self-funded employers and is pitched as stop-loss...
By Dave Muoio 02:58 pm August 13, 2020
Driving digital diagnosis. Roche and Israeli life sciences investment firm aMoon announced plans this week to launch an early-stage investment program called StarFinder Lab. Focused on novel diagnostic technologies, in particular, with the help of AI data analysis and digital health tools, the program will provide funding, mentoring and other strategic support such as a physical office space...
By Dave Muoio 01:46 pm June 24, 2020
Verily and CVS Health are among the latest big names lending their health and technology expertise to reopening businesses. Both companies have announced new enterprise offerings incorporating COVID-19 testing, symptom checking, clinical support, data analysis and app-based tools for employees. Verily's approach, called Healthy at Work, incorporates local, onsite and mail testing services into a...
By Dave Muoio 03:30 pm June 9, 2020
Apple COVID screener now updates the CDC. A COVID-19 screening tool first released by Apple in late March can now report users' symptoms, location, health background and other health characteristics to the CDC. The goal is to help the public health agency aggregate more incidence and case data, which can be used to better inform the public about the disease and its risk factors. These data are...
By Dave Muoio 03:23 pm March 16, 2020
Alphabet's Verily has launched a website where California residents can complete a short survey regarding their current condition and, if they meet certain criteria, could be referred to a nearby mobile COVID-19 testing site. Conducted through Verily's Project Baseline population health effort and developed in collaboration with federal, state and local public health authorities, the triage...
By MobiHealthNews 03:55 pm March 3, 2020
Fitbit and Belgium-based FibriCheck have extended their partnership to bring the latter’s atrial fibrillation detection app to four new countries in the EU: France, Germany, Italy and Spain. It was previously made available to Fitbit smartwatch users in the UK, Ireland, the Netherlands and Belgium back in September 2019. “For more than a decade, Fitbit has helped millions of people around the...
By Dave Muoio 03:22 pm February 26, 2020
Type 2 diabetes patients who received a continuous glucose monitoring (CGM) system as part of a virtual diabetes clinic program improved their HbA1c and near-uniformly said they were comfortable self-inserting a sensor with guidance from a remote coach, according to study data presented by Onduo at an academic conference last weekend. Further, while more than half of the study’s nearly 600...
By Dave Muoio 11:13 am January 22, 2020
Editor's note: This story has been updated with information from Verily's announcement of the clearance.  Verily, the life sciences research subsidiary of Alphabet, has received FDA 510(k) clearance for an augmented version of its prescription Study Watch wearable that includes some form of arrhythmia monitoring. The Study Watch With Irregular Pulse Monitor is classified by the FDA as a “...
By Jonah Comstock 09:49 am January 21, 2020
One of the biggest digital health success stories of the two decades is in the diabetes space, especially the continuous glucose monitor (or CGM). The first CGM was approved by the FDA in 1999, but in the last decade we've seen CGMs become smaller, longer lasting and more comfortable, and we've seen huge strides in datasharing as CGM-phone connectivity went from novelty to commodity.  Dexcom has...